Lotuspharm Manufacturing Private Limited
About Lotuspharm Manufacturing Private Limited
Data last updated:
Lotuspharm Manufacturing Private Limited is a private limited company based in Delhi, India. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 15 April 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85100DL2013PTC250763. Its GSTIN is 07AACCL4682L1Z4 (Delhi).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1.73 Lakh. It is led by directors Vijay Kumar Singh and Raj Kumar Shukla.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at J – 60 Second Floor, Paryavaran Complex Saidulajab, Delhi, India – 110068.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.86 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹93.26 Lakh (net margin 19.2%) and EBITDA of ₹1.26 Cr (EBITDA margin 25.9%). Revenue has grown at a compounded annual rate (CAGR) of 232% over three years and 84% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Lotuspharm Manufacturing Private Limited's registered office is in Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressJ – 60 Second Floor, Paryavaran Complex Saidulajab, Delhi, India – 110068
- IndustryHealthcare, Medical & Laboratory Equipment
To see the full contact details of Lotuspharm Manufacturing Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Lotuspharm Manufacturing is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Lotuspharm Manufacturing Private Limited, buy the company report.
Financials of Lotuspharm Manufacturing Private Limited
FY 2025 filings availableLotuspharm Manufacturing Private Limited reported revenue of ₹4.86 Cr (up 208% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 84% over five years, including 208% growth in the latest year. EBITDA rose 636% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.26 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹93.26 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 25.9% | ||||
| Net Profit Margin | 19.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Lotuspharm Manufacturing Private Limited, buy the company report.
Board of directors of Lotuspharm Manufacturing Private Limited
Lotuspharm Manufacturing has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vijay Kumar Singh | Director | 15 Apr 2013 | 13 Years 6 Months | Current |
| Raj Kumar Shukla Also directs: Purpose Holding Private Limited | Director | 28 Feb 2014 | 12 Years 7 Months | Current |
Auditor
Lotuspharm Manufacturing Private Limited is audited by A K A R & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A K A R & ASSOCIATES | FY 2020 | 003753N |
Shareholding
The shareholding of Lotuspharm Manufacturing Private Limited is on record for 4 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Lotuspharm Manufacturing Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Lotuspharm Manufacturing Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Lotuspharm Manufacturing Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Lotuspharm Manufacturing has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AACCL4682L1Z4 | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Lotuspharm Manufacturing Private Limited, buy the company report.
Recent activity
Lotuspharm Manufacturing Private Limited has 4 board changes on record since 2013: 2 appointments and 2 cessations. The latest: Siarhei Khvoshch ceased to be Director on 02 Jun 2018.
Frequently asked questions
Lotuspharm Manufacturing is an active private limited company based in Delhi, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 15 April 2013 (13+ years old) and is registered under CIN U85100DL2013PTC250763.
Lotuspharm Manufacturing has 2 current directors:
- Vijay Kumar Singh - Director
- Raj Kumar Shukla - Director
The latest financial statements of Lotuspharm Manufacturing on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Lotuspharm Manufacturing is 07AACCL4682L1Z4, registered in Delhi.
The CIN (Corporate Identification Number) of Lotuspharm Manufacturing is U85100DL2013PTC250763. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lotuspharm Manufacturing was incorporated on 15 April 2013, making it 13+ years old. It is registered with the Registrar of Companies, Delhi.
Siarhei Khvoshch ceased to be Director on 02 Jun 2018. Raj Kumar Shukla ceased to be Additional Director on 30 Sep 2014. Raj Kumar Shukla was appointed as Director on 28 Feb 2014. Lotuspharm Manufacturing has 4 board changes on record in total.
The registered office of Lotuspharm Manufacturing is at J – 60 Second Floor, Paryavaran Complex Saidulajab, Delhi, India – 110068.
Lotuspharm Manufacturing operates in the healthcare industry, in the medical and laboratory equipment segment.
The compliance status of Lotuspharm Manufacturing is compliant as of 08 July 2026. The company is actively filing with the Registrar of Companies.